Arbutus Biopharma Corp (ABUS) operating margin is 94.4%
Arbutus Biopharma Corp (ABUS) operating margin is 94.4% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full ABUS research page for quote, filings, and the rest of the model. This satellite exists so “Arbutus Biopharma Corp operating margin” can rank with the actual number, then send you to /stock/abus.